Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Becker Muscular Dystrophy

1-methyl-3-isobutylxanthine has been researched along with Becker Muscular Dystrophy in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research Excerpts

ExcerptRelevanceReference
"Duchenne muscular dystrophy is a genetic disorder for which no cure exists."1.43Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle. ( Fu, D; Lala-Tabbert, N; Wiper-Bergeron, N, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lala-Tabbert, N1
Fu, D1
Wiper-Bergeron, N1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Becker Muscular Dystrophy

ArticleYear
Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
    Stem cells translational medicine, 2016, Volume: 5, Issue:4

    Topics: 1-Methyl-3-isobutylxanthine; Animals; CCAAT-Enhancer-Binding Protein-beta; Cell Proliferation; Cells

2016